22. Income Taxes

 

The components of the pretax income (loss) from operations for the years ended December 31, 2025 and 2024 are as follows:

 

 

 

Years Ended December 31,

 

 

 

2025

 

 

2024

 

Domestic (U.S. operations)

 

$(7,159,752)

 

$(25,131,654)

Foreign (PRC operations)

 

 

(300,191)

 

 

(8,166,852)

Income (loss) before income taxes

 

$(7,459,943)

 

$(33,298,506)

 

The income tax provisions (benefits) for the years ended December 31, 2025 and 2024 are as follows:

 

 

 

Years Ended December 31,

 

 

 

2025

 

 

2024

 

Current

 

 

 

 

U.S. federal

 

$-

 

 

$-

 

State and local

 

 

68,331

 

 

 

6,000

 

Foreign (PRC operations)

 

 

197,475

 

 

 

(173,904)

Total current income tax expense (benefit)

 

 

265,806

 

 

 

(167,904)

Deferred

 

 

 

 

 

 

 

 

U.S. federal

 

 

-

 

 

 

-

 

State and local

 

 

-

 

 

 

-

 

Foreign (PRC operations)

 

 

(1,400,381)

 

 

1,831,734

 

Total deferred income tax expense (benefit)

 

 

(1,400,381)

 

 

1,831,734

 

Income tax expense (benefit)

 

$(1,134,575)

 

$1,663,830

 

 

Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, as described in Note 2, Summary of Significant Accounting Policies, the reconciliation of taxes at the federal statutory rate to our provision for (benefit from) income taxes for the year ended December 31, 2025 was as follows:

 

 

 

December 31, 2025

 

 

 

Rate

 

 

Amount

 

Income taxes at statutory rates

 

 

21.00%

 

$(1,566,588)

State taxes in Texas and made up the majority (greater than 50%) of the tax effect in this category, net of federal benefit

 

 

(0.72)%

 

 

53,982

 

Foreign rate differential

 

 

 

 

 

 

 

 

China

 

 

 

 

 

 

 

 

Valuation allowance

 

 

15.22%

 

 

(1,135,313)

Other

 

 

0.06%

 

 

(4,554)

Effects of cross-border tax laws

 

 

(0.12)%

 

 

8,777

 

Tax credits

 

-

%

 

 

-

 

Change in valuation allowance

 

 

(7.02)%

 

 

523,459

 

Nontaxable or nondeductible items

 

 

 

 

 

 

 

 

Non-deductible interest expense 163(l)- Convertible debt

 

 

(2.28)%

 

 

169,947

 

Debt Extinguishment Loss

 

 

(2.79)%

 

 

207,822

 

Other

 

 

(0.16)%

 

 

12,172

 

Other adjustments

 

 

 

 

 

 

 

 

Executives Compensation

 

 

(7.29)%

 

 

543,974

 

Equity investment basis true-up

 

 

 (1.08

)% 

 

 

 80,875

 

Other adjustment

 

 

0.39%

 

 

(29,128

Effective income tax rate

 

 

15.21%

 

$(1,134,575)

 

 

December 31, 2024

 

 

 

Rate

 

 

Amount

 

Income taxes at statutory rates

 

 

21.00%

 

$(6,992,686)

State income tax, net of federal benefit

 

 

4.05%

 

 

(1,348,747)

Foreign rate differential

 

 

0.08%

 

 

(26,723)

Non-deductible interest

 

 

(0.53)%

 

 

177,673

 

Other permanent items

 

 

(0.04)%

 

 

13,621

 

Goodwill impairment

 

 

(4.71)%

 

 

1,566,997

 

Section 162(m) adjustment

 

 

(2.37)%

 

 

788,746

 

Stock-based compensation

 

 

(0.05)%

 

 

17,694

 

Subpart F

 

 

(0.02)%

 

 

6,721

 

State rate change

 

 

(0.05)%

 

 

16,231

 

Return-to-provision true-up

 

 

0.22%

 

 

(73,256)

Change in valuation allowance

 

 

(22.16)%

 

 

7,469,750

 

Other adjustment

 

 

(0.42)%

 

 

47,809

 

Effective income tax rate

 

 

(5.00)%

 

$1,663,830

 

 

The amount of cash income taxes paid  (refunded) by the Company for the year ended December 31, 2025 are as follows:

 

 

 

December 31,

2025

 

 

 

 

 

U.S. operations

 

 

 

State

 

$8,537

 

Foreign

 

 

 

 

PRC operations

 

 

162,402

 

Total

 

$170,939

 

 

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities as of December 31, 2025 and 2024 are as follows:

 

 

 

 December 31,

 

 

 

2025

 

 

 2024

 

Deferred tax assets

 

 

 

 

Investment credit

 

$1,037,362

 

 

$1,037,362

 

Net operating loss carryforwards

 

 

17,712,635

 

 

 

16,836,965

 

Stock-based compensation and accrued bonus

 

 

2,958,932

 

 

 

4,078,345

 

Depreciation

 

 

35,156

 

 

 

62,445

 

Operating lease liabilities

 

 

399,721

 

 

 

907,557

 

Contract accounting

 

 

3,364,768

 

 

 

3,029,238

 

Other

 

 

1,159,764

 

 

 

1,396,714

 

Total deferred tax assets

 

 

26,668,338

 

 

 

27,348,626

 

Valuation allowance

 

 

(23,755,429)

 

 

(25,132,983)

Total deferred tax assets, net of allowance

 

 

2,912,909

 

 

 

2,215,643

 

Deferred tax liabilities

 

 

 

 

 

 

 

 

Operating lease right-of-use assets

 

 

(382,521)

 

 

(878,693)

Contract Accounting

 

 

(2,782,194)

 

 

(2,957,445)

Total deferred tax liabilities

 

 

(3,164,715)

 

 

(3,836,138)

Deferred tax assets (liability), net

 

$(251,806)

 

$(1,620,495)

 

The Company has established a valuation allowance against its net deferred tax assets due to the uncertainty surrounding the realization of such assets. The Company periodically evaluates the recoverability of the deferred tax assets. At such time as it is determined that it is more likely than not that deferred assets are realizable, the valuation allowance will be reduced. The Company has recorded a valuation allowance of $23.8 million as of December 31, 2025 as it does not believe it is more likely than not that certain deferred tax assets will be realized primarily due to the generation of pre-tax book losses in the current year, the lack of feasible tax-planning strategies, the limited existing taxable temporary differences, and the subjective nature of forecasting future taxable income into the future. The Company decreased its valuation allowance by approximately $1.4 million during the year ended December 31, 2025.

 

As of December 31, 2025, the Company had federal and state tax net operating loss ("NOL”) carryforwards of $62.2 million, and $65.6 million, respectively. The federal NOL generated in 2018 and after for the amount of $39.8 million will carry forward indefinitely and be available to offset up to 80% of future taxable income each year. The remaining federal and state NOL carryforwards will begin to expire in 2031, and the state NOL carryforwards will begin to expire in 2032 unless previously utilized. The Company also had China NOL carryforwards of approximately $400,000 as of December 31, 2025. The China NOL will begin to expire in 2027, unless previously utilized. In addition, as of December 31, 2025 the Company had investment tax credits of $1.0 million, for building qualifying energy properties and projects under IRC section 48, which will expire in 2034.

 

The above NOL carryforwards and the investment tax credit carryforwards are subject to limitation under Sections 382 and 383 of the Internal Revenue Code of 1986, and similar state provisions which limit the amount NOL and tax credit carryforwards that can be utilized to offset future taxable income and tax, respectively. In general, an ownership change, as defined by Sections 382 and 383, results from transactions increasing ownership of certain stockholders or public groups in the stock of the corporation by more than 50 percentage points over a three-year period. The Company has performed an IRC Section 382 as of December 31, 2020, in which it was determined that no significant change in ownership had occurred. In addition, the Company has not experienced the ownership change greater than 50% subsequent to December 31, 2020 and up to 2025.

 

The following table summarizes the reconciliation of the unrecognized tax benefits activity during the years ended December 31, 2025 and 2024:

 

 

 

 December 31,

 

 

 

2025

 

 

 2024

 

Unrecognized tax benefits – beginning

 

$2,137,790

 

 

$2,137,790

 

Increases (decreases) related to current year tax positions

 

 

-

 

 

 

-

 

Increases (decreases) related to prior year tax positions

 

 

-

 

 

 

-

 

Expiration of the statute of limitations for the assessment of taxes

 

 

-

 

 

 

-

 

Other

 

 

-

 

 

 

-

 

Unrecognized tax benefits – ending

 

$2,137,790

 

 

$2,137,790

 

 

Included in the balance of unrecognized tax benefits as of December 31, 2025, is $1.9 million that, if recognized, would not impact the Company's income tax benefit or effective tax rate as long as the deferred tax asset remains subject to a full valuation allowance. The Company does not foresee material changes to its liability for uncertain tax benefits within the next twelve months.

 

The Company's policy is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had no accrual for interest or penalties on the Company's balance sheets as of December 31, 2025 and has not recognized interest and/or penalties in the Statement of Operations for the year ended December 31, 2025.

 

The Company is subject to taxation in the United States, various state jurisdictions and China. Due to the existence of federal, state, and foreign net operating loss and credit carryovers, the Company's tax years that remain open and subject to examination by tax jurisdiction are years 2011 forward for federal and years 2012 and forward for the state.

 

The Company’s PRC subsidiaries are subject to a 25% statutory income tax rate according to the PRC's income tax laws. Tax regulations are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. All tax positions taken, or expected to be taken, continue to be more likely than not ultimately settled at the full amount claimed. The Company's PRC subsidiaries' tax filings are subject to the PRC tax bureau’s examination for a period up to five years. These subsidiaries are not currently under examination by the PRC tax bureau.

 

As of December 31, 2025, the Company’s foreign subsidiaries operated at a cumulative deficit for U.S. earnings and profit purposes. The Company does not record U.S. income taxes on the undistributed earnings of its foreign subsidiaries based upon the Company’s intention to permanently reinvest undistributed earnings to ensure sufficient working capital and further expansion of existing operations outside the U.S. In the event the Company is required to repatriate funds from outside of the U.S., such repatriation would be subject to local laws, customs, and tax consequences. Determination of the amount of unrecognized deferred tax liability related to these earnings is not practicable.

 

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. ASU 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company adopted this standard prospectively for the period ending December 31, 2025. The adoption impacted the Company's income tax disclosures only and did not otherwise impact the Company's financial statements.

 

On July 4, 2025, the reconciliation bill commonly referred to as the One Big Beautiful Bill Act (“OBBBA”) was signed into law in the United States. The OBBBA includes a broad range of tax reform provisions affecting U.S. corporate income taxation. Certain provisions became effective beginning in 2025, including an elective deduction for domestic research and development expenditures, reinstatement of 100% first-year bonus depreciation, and repeal of the fiscal year-end requirement for certain non-U.S. corporations. Other provisions of the OBBBA will become effective in 2026 and subsequent years, including a more favorable tax rate applicable to Foreign-Derived Deduction Eligible Income and income from non-U.S. subsidiaries (Net CFC Tested Income). Due to the Company’s full valuation allowance on deferred tax assets, the enactment of the OBBBA did not have a material impact on the Company’s financial statements for the year ended December 31, 2025.

Historical Timeline

Fiscal YearFiled
2025Apr 6, 2026Showing above
2024Mar 31, 2025

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.